Phase 1 study of PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor, for the treatment of acute myeloid leukemia and myelodysplastic syndrome
- G. J. Roboz
- , F. J. Giles
- , A. F. List
- , J. E. Cortes
- , R. Carlin
- , M. Kowalski
- , S. Bilic
- , E. Masson
- , M. Rosamilia
- , M. W. Schuster
- , D. Laurent
- , E. J. Feldman
- Joan and Sanford I. Weill Department of Medicine
- Department of Cancer Biology
- University of Arizona Cancer Center
- Novartis Institutes for Biomedical Research
- R & amp;D
Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review
75
Citations
(Scopus)